Recent News

Sexual function concerns not always reflected in prostate cancer treatment choices

Sexual function concerns not always reflected in prostate cancer treatment choices

A study led by UNC Lineberger's Ronald C. Chen, MD, MPH, found that preference for preserving sexual function was not strongly reflected in the treatment choices of men with low-risk prostate cancer.

Sexual function concerns not always reflected in prostate cancer treatment choices - Read More…

Timing could matter to how responsive cancer cells are to treatment, study suggests

Timing could matter to how responsive cancer cells are to treatment, study suggests

In a new study published in Cell Systems, UNC Lineberger's Jeremy Purvis, PhD, and colleagues report that the timing of when DNA damage occurs within these different checkpoints matters to a cell’s fate.

Timing could matter to how responsive cancer cells are to treatment, study suggests - Read More…

Using new knowledge about cell division, researchers look to improve chemotherapy effects

Using new knowledge about cell division, researchers look to improve chemotherapy effects

A study led by UNC Lineberger member Michael J. Emanuele, PhD, was featured on the cover of The Journal of Biological Chemistry. The researchers uncovered new details about a protein called NUSAP1 during chromosome segregation, and offered a possible way to sensitize cancer cells to a particular type of chemotherapy.

Using new knowledge about cell division, researchers look to improve chemotherapy effects - Read More…

Sharpless sworn in as National Cancer Institute director

Sharpless sworn in as National Cancer Institute director

Norman E. Sharpless, MD, who served as director of the UNC Lineberger Comprehensive Cancer Center from January 2014-June 2017, was formally sworn in as director of the National Cancer Institute on Oct. 17.

Sharpless sworn in as National Cancer Institute director - Read More…